Earlier this week, Axios reported that Humana Inc. (NYSE: HUM) is gearing up for a sale of Kindred at Home’s hospice business and seeking a multiple of 12 times EBITDA. Two days later, Encompass Health Corporation (NYSE: EHC) reaffirmed its plan to spin off its home health and hospice segment into a new publicly traded entity.
Add to that a decent-sized home health acquisition announced by Amedisys Inc. (Nasdaq: AMED), also on Wednesday, and you have yourself some interesting M&A tea leaves to read for 2022.
Sign up for HHCN + to read this exclusive content.
Need more than 5 members? Contact us for more information.
* per member
Already a member?
The post Recent Deals Suggest 2022 Will Bring a Very Different M&A Market for Home Health, Hospice appeared first on Home Health Care News.
